Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils

M. Nabe, Devendra K. Agrawal, E. U. Sarmiento, R. G. Townley

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The effect of terfenadine on histamine release from human basophils and LTC4 production and release from human eosinophils was evaluated. Eosinophils and basophils were obtained by discontinuous gradient centrifugation of the peripheral blood of atopic asthma patients who were off medication. Anti-IgE-induced histamine release from human basophils was significantly inhibited by terfenadine. Maximum inhibition was obtained at 1 x 10-5 M terfenadine (percentage inhibition = 57.0 ± 20.1; P <0.05). However, only the highest dose of terfenadine used in this study, i.e. 2 x 10-5 M, significantly inhibited calcium ionophore (A23187)-induced histamine release from human basophils (percentage inhibition = 40.0 ± 14.6; P <0.05), and LTC4 production from human eosinophils (percentage inhibition 59.8 ± 9.9; P <0.05). These findings demonstrate that terfenadine, in addition to its known antihistaminic property, also has an inhibitory effect on chemical mediator release.

Original languageEnglish
Pages (from-to)515-520
Number of pages6
JournalClinical and Experimental Allergy
Volume19
Issue number5
StatePublished - 1989

Fingerprint

Terfenadine
Basophils
Eosinophils
Histamine Release
Leukotriene C4
Calcium Ionophores
Calcimycin
Centrifugation
Asthma

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils. / Nabe, M.; Agrawal, Devendra K.; Sarmiento, E. U.; Townley, R. G.

In: Clinical and Experimental Allergy, Vol. 19, No. 5, 1989, p. 515-520.

Research output: Contribution to journalArticle

@article{6ee08250662c49108bba23ee477f1c6d,
title = "Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils",
abstract = "The effect of terfenadine on histamine release from human basophils and LTC4 production and release from human eosinophils was evaluated. Eosinophils and basophils were obtained by discontinuous gradient centrifugation of the peripheral blood of atopic asthma patients who were off medication. Anti-IgE-induced histamine release from human basophils was significantly inhibited by terfenadine. Maximum inhibition was obtained at 1 x 10-5 M terfenadine (percentage inhibition = 57.0 ± 20.1; P <0.05). However, only the highest dose of terfenadine used in this study, i.e. 2 x 10-5 M, significantly inhibited calcium ionophore (A23187)-induced histamine release from human basophils (percentage inhibition = 40.0 ± 14.6; P <0.05), and LTC4 production from human eosinophils (percentage inhibition 59.8 ± 9.9; P <0.05). These findings demonstrate that terfenadine, in addition to its known antihistaminic property, also has an inhibitory effect on chemical mediator release.",
author = "M. Nabe and Agrawal, {Devendra K.} and Sarmiento, {E. U.} and Townley, {R. G.}",
year = "1989",
language = "English",
volume = "19",
pages = "515--520",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils

AU - Nabe, M.

AU - Agrawal, Devendra K.

AU - Sarmiento, E. U.

AU - Townley, R. G.

PY - 1989

Y1 - 1989

N2 - The effect of terfenadine on histamine release from human basophils and LTC4 production and release from human eosinophils was evaluated. Eosinophils and basophils were obtained by discontinuous gradient centrifugation of the peripheral blood of atopic asthma patients who were off medication. Anti-IgE-induced histamine release from human basophils was significantly inhibited by terfenadine. Maximum inhibition was obtained at 1 x 10-5 M terfenadine (percentage inhibition = 57.0 ± 20.1; P <0.05). However, only the highest dose of terfenadine used in this study, i.e. 2 x 10-5 M, significantly inhibited calcium ionophore (A23187)-induced histamine release from human basophils (percentage inhibition = 40.0 ± 14.6; P <0.05), and LTC4 production from human eosinophils (percentage inhibition 59.8 ± 9.9; P <0.05). These findings demonstrate that terfenadine, in addition to its known antihistaminic property, also has an inhibitory effect on chemical mediator release.

AB - The effect of terfenadine on histamine release from human basophils and LTC4 production and release from human eosinophils was evaluated. Eosinophils and basophils were obtained by discontinuous gradient centrifugation of the peripheral blood of atopic asthma patients who were off medication. Anti-IgE-induced histamine release from human basophils was significantly inhibited by terfenadine. Maximum inhibition was obtained at 1 x 10-5 M terfenadine (percentage inhibition = 57.0 ± 20.1; P <0.05). However, only the highest dose of terfenadine used in this study, i.e. 2 x 10-5 M, significantly inhibited calcium ionophore (A23187)-induced histamine release from human basophils (percentage inhibition = 40.0 ± 14.6; P <0.05), and LTC4 production from human eosinophils (percentage inhibition 59.8 ± 9.9; P <0.05). These findings demonstrate that terfenadine, in addition to its known antihistaminic property, also has an inhibitory effect on chemical mediator release.

UR - http://www.scopus.com/inward/record.url?scp=0024435806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024435806&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 515

EP - 520

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 5

ER -